CertaraMEX:CERT 60 EBIT per Share is MXN1.74 as of Mar. 2026. GuruFocus rates MEX:CERT with a GF Score™ of 60/100 and a GF Value™ of MXN535.16. The stock has 2 warning signs investors should review. Among 530 Healthcare Providers & Services companies, Certara ranks worse than 83.02% on this metric.
Certara's EBIT per Share for the
three
months ended in Mar. 2026 was MXN-0.34.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN1.74.
During the past 12 months, the average EBIT per Share Growth Rate of Certara was 27.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -13.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Certara's EBIT per Share or its related term are showing as below:
MEX:CERT'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -13.7 Med: 1.55 Max: 16.8
Current: -13.7
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Certara was 16.80% per year. The lowest was -13.70% per year. And the median was 1.55% per year.
MEX:CERT's 3-Year EBIT Growth Rate is ranked worse than 83.02% of 530
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs MEX:CERT: -13.70
Certara's EBIT for the
three
months ended in Mar. 2026 was MXN-54 Mil.
Certara (MEX:CERT) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Certara EBIT per Share Related Terms
Certara EBIT per Share Historical Data
* Premium members only.
The historical data trend for Certara's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Certara (MEX:CERT) has a EBIT per Share of MXN1.74 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Certara and its competitors. According to the industry distribution chart, Certara ranks #440 out of 530 companies in the Healthcare Providers & Services industry, placing it in the top 83%.
Is Certara's EBIT per Share too high?
Certara's current EBIT per Share is MXN1.74. Based on the distribution chart, Certara ranks #440 out of 530 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Certara has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Certara's EBIT per Share compare to TALK and GDRX?
According to the Healthcare Providers & Services industry distribution chart, Certara ranks #440 out of 530 companies for EBIT per Share. This places Certara in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 530 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Certara and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Certara's current EBIT per Share is MXN1.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Certara (MEX:CERT) has a current EBIT per Share of MXN1.74. The stock's GF Value™ is MXN535.16, compared to a current price of MXN254.00 — trading 52.5% below its estimated fair value. The current EBIT per Share is MXN1.74. Certara's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Certara (MEX:CERT), the current EBIT per Share is MXN1.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Certara (MEX:CERT) Overvalued in 2026?
Based on GuruFocus' analysis, Certara stock appears to be undervalued.
The current stock price of MXN254.00 is trading 52.5% below its estimated GF Value™ of MXN535.16.
Key valuation signals for MEX:CERT:
EBIT per Share: MXN1.74
GF Value™: MXN535.16 vs. price of MXN254.00 (52.5% below fair value)
No single metric tells the full story. See the MEX:CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
60GF Score
Get the complete analysis for MEX:CERT
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CERT has been successfully added to your 
